Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 2, Pages e31070
Publisher
Public Library of Science (PLoS)
Online
2012-02-16
DOI
10.1371/journal.pone.0031070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polymalic Acid–Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity
- (2011) Satoshi Inoue et al. CANCER RESEARCH
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Multifunctional Tumor-Targeted Polymer-Peptide-Drug Delivery System for Treatment of Primary and Metastatic Cancers
- (2010) Pooja Chandna et al. PHARMACEUTICAL RESEARCH
- Inhibition of brain tumor growth by intravenous poly( -L-malic acid) nanobioconjugate with pH-dependent drug release
- (2010) H. Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thermal Enhancement with Optically Activated Gold Nanoshells Sensitizes Breast Cancer Stem Cells to Radiation Therapy
- (2010) R. L. Atkinson et al. Science Translational Medicine
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
- (2009) T. A. ElBayoumi et al. CLINICAL CANCER RESEARCH
- Dose-dependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
- (2009) B Wu et al. GENE THERAPY
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer
- (2009) John F. Flynn et al. Journal of Oncology
- Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
- (2008) H. Maeda et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Tumor-specific antibody-mediated targeted delivery of Doxil® reduces the manifestation of auricular erythema side effect in mice
- (2008) Tamer A. Elbayoumi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery
- (2008) Julia Y Ljubimova et al. Nanomedicine
- Nanoconjugate based on polymalic acid for tumor targeting
- (2007) Julia Y. Ljubimova et al. CHEMICO-BIOLOGICAL INTERACTIONS
- c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model
- (2007) Harmanjatinder S. Sekhon et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now